Terms: = Germ cell tumor AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Clinical Outcome
8 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Impact of extent of resection and adjuvant therapy in diffuse gliomas of the spine.
Chalif EJ; Foster C; Sack K; Patrick H; Mozaffari K; Rosner M
Spine J; 2023 Jul; 23(7):1015-1027. PubMed ID: 36804437
[TBL] [Abstract] [Full Text] [Related]
3. Chromosomal instability in adult-type diffuse gliomas.
Richardson TE; Walker JM; Abdullah KG; McBrayer SK; Viapiano MS; Mussa ZM; Tsankova NM; Snuderl M; Hatanpaa KJ
Acta Neuropathol Commun; 2022 Aug; 10(1):115. PubMed ID: 35978439
[TBL] [Abstract] [Full Text] [Related]
4. Can a signature molecular-profile define disparate survival in BRAF-positive Gliosarcoma and identify novel targets for therapeutic intervention?
Gandhi P; Khare R; Garg N; Mishra J
J Cancer Res Ther; 2022; 18(1):224-230. PubMed ID: 35381788
[TBL] [Abstract] [Full Text] [Related]
5. A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small cell Lung Cancer.
Dizier B; Callegaro A; Debois M; Dreno B; Hersey P; Gogas HJ; Kirkwood JM; Vansteenkiste JF; Sequist LV; Atanackovic D; Goeman J; van Houwelingen H; Salceda S; Wang F; Therasse P; Debruyne C; Spiessens B; Brichard VG; Louahed J; Ulloa-Montoya F
Clin Cancer Res; 2020 Apr; 26(7):1725-1735. PubMed ID: 31732522
[TBL] [Abstract] [Full Text] [Related]
6. [The latest diagnostical methods and therapy in melanoma].
Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
[TBL] [Abstract] [Full Text] [Related]
7. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.
Michalowski MB; de Fraipont F; Michelland S; Entz-Werle N; Grill J; Pasquier B; Favrot MC; Plantaz D
Cancer Genet Cytogenet; 2006 Apr; 166(1):74-81. PubMed ID: 16616114
[TBL] [Abstract] [Full Text] [Related]
8. Reduced infiltration of class A scavenger receptor positive antigen-presenting cells is associated with prostate cancer progression.
Yang G; Addai J; Tian WH; Frolov A; Wheeler TM; Thompson TC
Cancer Res; 2004 Mar; 64(6):2076-82. PubMed ID: 15026346
[TBL] [Abstract] [Full Text] [Related]
